Search results
Showing 76 to 90 of 142 results for pneumonia
This quality standard covers managing intravenous (IV) fluid therapy safely and effectively for adults in hospital. It describes high-quality care in priority areas for improvement.
View quality statements for QS66Show all sections
Sections for QS66
How cost effective are fluoride varnish programmes and tooth-brushing schemes?
pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...
pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...
This guideline covers rehabilitation after stroke for over 16s. It aims to ensure people are assessed for common problems and conditions linked to stroke, and get the care and therapy they need. It includes recommendations on the organisation and delivery of rehabilitation in hospital and the community.
Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing (NG117)
This guideline sets out an antimicrobial prescribing strategy for managing and preventing acute exacerbations of bronchiectasis (non-cystic fibrosis). It aims to optimise antibiotic use and reduce antibiotic resistance.
pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...
pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...
pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...
pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant (TA640)
Evidence-based recommendations on treosulfan (Trecondi) with fludarabine for conditioning treatment before allogeneic haematopoietic stem cell transplant for malignant diseases in people for whom a reduced intensity regimen would be suitable.
pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis (TA199)
Evidence-based recommendations on etanercept (Enbrel), infliximab (Remicade) and adalimumab (Humira) for treating active and progressive psoriatic arthritis in adults.
View recommendations for TA199Show all sections
This guideline covers oral health, including dental health and daily mouth care, for adults in care homes. The aim is to maintain and improve their oral health and ensure timely access to dental treatment.
This guideline covers the general principles for managing intravenous (IV) fluid therapy in hospital inpatients aged 16 and over with a range of conditions. It aims to help prescribers understand the optimal amount and composition of IV fluids to be administered and the best rate at which to give them, to improve fluid prescribing and outcomes among people in hospital. It does not cover pregnant women, and those with severe liver or renal disease, diabetes or burns.
This quality standard covers the management of Parkinson’s disease in adults. It does not include treatment of parkinsonism not caused by Parkinson’s disease. It describes high-quality care in priority areas for improvement.
View quality statements for QS164Show all sections
Sections for QS164
- Quality statements
- Quality statement 1: Point of contact with specialist services
- Quality statement 2: Information about impulse control disorders
- Quality statement 3: Referral to physiotherapy, occupational therapy or speech and language therapy
- Quality statement 4: Levodopa in hospital or a care home
- Quality statement 5: Access to clozapine for treating hallucinations and delusions
- About this quality standard